Synergistic and Additive Effects of Epigallocatechin Gallate and Digitonin on Plasmodium Sporozoite Survival and Motility by Hellmann, Janina K. et al.
Synergistic and Additive Effects of Epigallocatechin
Gallate and Digitonin on Plasmodium Sporozoite
Survival and Motility
Janina K. Hellmann




1Department of Infectious Diseases, University of Heidelberg Medical School, Heidelberg, Germany, 2Department of Biology, University of Heidelberg, Heidelberg,
Germany
Abstract
Background: Most medicinal plants contain a mixture of bioactive compounds, including chemicals that interact with
intracellular targets and others that can act as adjuvants to facilitate absorption of polar agents across cellular membranes.
However, little is known about synergistic effects between such potential drug candidates and adjuvants. To probe for such
effects, we tested the green tea compound epigallocatechin gallate (EGCG) and the membrane permeabilising digitonin on
Plasmodium sporozoite motility and viability.
Methodology/Principal Findings: Green fluorescent P. berghei sporozoites were imaged using a recently developed visual
screening methodology. Motility and viability parameters were automatically analyzed and IC50 values were calculated, and
the synergism of drug and adjuvant was assessed by the fractional inhibitory concentration index. Validating our visual
screening procedure, we showed that sporozoite motility and liver cell infection is inhibited by EGCG at nontoxic
concentrations. Digitonin synergistically increases the cytotoxicity of EGCG on sporozoite survival, but shows an additive
effect on sporozoite motility.
Conclusions/Significance: We proved the feasibility of performing highly reliable visual screens for compounds against
Plasmodium sporozoites. We thereby could show an advantage of administering mixtures of plant metabolites on inhibition
of cell motility and survival. Although the effective concentration of both drugs is too high for use in malaria prophylaxis,
the demonstration of a synergistic effect between two plant compounds could lead to new avenues in drug discovery.
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Introduction
Plant-derived bioactive compounds are attractive candidates for
drug development since they represent lead structures for new or
existing drug targets. Currently, most medications including
antibiotics, anticancer drugs and drugs directed against parasites
are based on natural compounds [1,2,3]. The active substances in
plants are mostly secondary metabolites, which are used as defense
compounds against predators or parasites, for interspecies
competition or as signal compounds to attract insects or other
animals [4]. Plants usually produce and store complex mixtures of
compounds from different structural classes to simultaneously
interfere with several targets, which is thought to amplify their
efficiency and reduce the risk of resistance development by
pathogens [5]. While many classes of secondary metabolites
interfere with specific molecular targets members of one major
secondary metabolite class called polyphenols interact non-
selectively like ‘‘protein glue’’ affecting any protein they encounter
[1,2]. Thus, they influence amongst others catalysis, transport, ion
exchange or signal transduction pathways of the targeted organism
[6,7].
Polyphenols can be divided in different families, for example the
flavonoids, which in turn include the group of catechins [5]. The
epigallocatechin gallate (EGCG) is the most effective and best-
studied catechin in green tea [8,9,10]. EGCG was shown to
generally inhibit metallo- and serine-proteases, proteasome
function, cell cycle regulation, tumor invasion, and to reduce
oxygen-derived free radicals [11,12,13]. Further, antibacterial
effects as well as inhibition of human immunodeficiency virus
(HIV) infection by EGCG were demonstrated [14,15]. Another
class of secondary plant metabolites are the so called terpenoids
that contain a family of steroids including the group of saponins
[16]. These saponins are together with polyphenols common in
most higher plants, being a highly heterogeneous group of
steroidal and triterpene glycosides [7,16,17]. Saponins are
amphiphilic compounds that can interact with biomembranes,
lyse cells or can form complexes with cholesterol. This interaction
influences membrane fluidity and renders membranes leaky. Due
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as synergistc effects as (vaccine) adjuvants for substances that are
normally not absorbed were also described [16,18,19]. The
saponin digitonin, an amphipathic, membrane-disrupting steroid,
is obtained from Digitalis purpurea [16].
Potential antimalarial properties of EGCG were also studied. It
has been shown that EGCG binds to the intercellular adhesion
molecule 1 (ICAM 1) on the endothelium thus blocking the
adhesion of Plasmodium infected erythrocytes [20]. EGCG further
inhibits Plasmodium falciparum growth in vitro and potentiates the
antimalarial effects of artemisinin [21]. Finally, the mechanism of
inhibition of an enoyl-acyl carrier protein reductase of Plasmodium
falciparum (PfENR) by EGCG was investigated resulting in the
inhibition of the fatty acid biosynthesis in the parasite [10].
Plasmodium sporozoites are the forms of the malaria parasite
injected into the host during a blood meal of the mosquito [22].
Sporozoites are deposited within the skin, where they can move at
a speed of around 1 mm/s [23,24]. Some sporozoites can enter
blood vessels and are transported to the liver, where they invade
hepatocytes to differentiate into red blood cell invading merozoites
[24,25]. While most efforts to design interventions against malaria
are focused on the blood stage of the parasite, which is responsible
for the symptoms of the disease, a number of studies provide a
good rationale for also focusing on the pre-erythrocyte stages [25].
However little effort is currently devoted to develop drugs against
these pre-erythrocyte stages of the malaria parasite, which could
prevent infection. We recently developed a methodology that
should in principle allow visual screening for substances that
inhibit sporozoite motility [26]. In order to verify this methodol-
ogy, we probe here the effect of EGCG in combination with the
adjuvant digitonin as a membrane permeabilising agent on
Plasmodium sporozoite motility and survival.
Results
Effect of EGCG on Plasmodium Sporozoite Survival,
Motility, and Liver Cell Infection
We first performed a cytotoxicity assay over 18 h with EGCG
concentrations ranging from 12.5 mg/ml to 2000 mg/ml (27 mM
to 4400 mM) by imaging Plasmodium sporozoites expressing the
green fluorescent protein (GFP). Living parasites were distin-
guished by their cytoplasmic green fluorescence from dead
parasites that lost their GFP signal, but were red fluorescent after
the uptake of SYTOX-Orange. When no drugs are added about
50% of the parasites died during the 18 h time course. Treatment
with 200 mg/ml EGCG showed that parasites first rounded up,
died and could then be found in the red channel (Figure 1A). After
6 h the first dead parasites were detected and after 12 h nearly all
parasites were dead. EGCG concentration curves for different
incubation times revealed a dose-dependent decrease of living
parasites and yielded IC50 values of 50262 mg/ml (109563 mM)
and 5462 mg/ml (11864 mM) for 6 h and 12 h incubation
periods, respectively (Figure 1B).
To test for a possible effect of EGCG on sporozoite gliding
motility, sporozoites exposed to EGCG concentrations ranging
from 3.125 to 500 mg/ml (6.75 to 1090 mM) were imaged 40 min
after incubation with the drugs. Maximum fluorescent intensity
projections of gliding parasites showed that gliding was inhibited to
around 50% and 100% after application of 100 mg/ml or 500 mg/
ml, respectively (Figure 2A). Analysis of the time lapse movies with
a recently developed tracking tool revealed a dose-dependent
inhibition of the gliding motility by EGCG with an IC50 value of
6361 mg/ml (13761 mM) (Figure 2B). At this concentration and
time point no effect of EGCG on sporozoite viability was detected.
Only after more than 5 h of incubation a small lethal effect with
,20% of sporozoites dying could be detected for this concentra-
tion. We next tested the effect of EGCG mediated inhibition of
sporozoite gliding on liver cell infection. Sporozoites treated with
different EGCG concentrations were either directly added to
Huh7 cells or after an incubation period of 40 min (pre-
incubation). This showed a dose dependent effect of EGCG on
liver stages (Figure 2C). As expected the effect of inhibition was
larger when sporozoites were pre-incubated with EGCG before
adding them to the liver cells. Curiously, the IC50 for inhibition of
liver cell infection was about two-fold higher as the IC50 for
inhibiting sporozoite gliding.
EGCG and Digitonin Act Synergistically to Kill Sporozoites
While the effect of EGCG on parasite gliding could be due to
the unspecific binding and blocking of proteins at the parasite
surface, the effect on viability could additionally be mediated by
interactions of EGCG with intracellular targets. Since EGCG does
not effectively cross the plasma membrane of the sporozoites, we
next determined possible membrane permeabilising effects of the
saponin digitonin. Snap shots of a pre-screen show that a digitonin
Figure 1. Cytotoxicity of EGCG on Plasmodium sporozoites. The
percentage of living parasites after application of different EGCG
concentrations from 12.5 mg/ml to 2000 mg/ml (27 mM - 4400 mM) was
determined over 18 h. A) Snap shots of parasites after treatment with
200 mg/ml EGCG at the start of the experiment and after 6 and 12 h.
The upper panels show the green, the lower panels the red fluorescent
signal. Living parasites are crescent shaped and show green fluores-
cence. Dying parasites are round and exhibit red fluorescence. Scale
bar: 25 mm; numbers indicate time in hours. B) The percentage of living
parasites (normalised to the control set to 100%) was plotted over the
concentrations of EGCG at 0 h (filled squares), after 6 h (open circles)
and 12 h (crosses). Weighted averages of the triplicates (each usually
contained between 200 and 300 sporozoites) and standard errors of the
mean of the percentage of living parasites for each data point are
shown. The dashed lines mark the IC50 values: 50262 mg/ml
(109563 mM) after 6 h, 5462 mg/ml (11864 mM) after 12 h.
doi:10.1371/journal.pone.0008682.g001
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killed the parasites within 40 min (Figure 3A). Reduction of the
digitonin concentration to 250 mg/ml showed that more than 50%
of the parasites are still alive after treatment (Figure 3A).
Cytotoxicity assays were then also performed for digitonin
concentrations in a range from 10 mg/ml to 1000 mg/ml over
18 h. The application of digitonin on sporozoites revealed a dose-
and time-dependent decrease of living parasites (Figure 3B). After
6 (12) h at 60 mg/ml digitonin 28% (52%) of sporozoites
respectively were killed.
To determine possible additive or synergistic effects we next
performed cytotoxicity assays over 18 h after application of
EGCG concentrations from 12.5 mg/ml to 1000 mg/ml together
with either 40, 50, 60 or 70 mg/ml digitonin. The data was
normalised to the measured death curves of 40, 50, 60 and 70 mg/
ml digitonin alone over 18 h since digitonin alone already had a
toxic effect (data not shown). Death curves at a fixed EGCG
concentration of 50 mg/ml or 200 mg/ml indicated that the toxic
effect of EGCG was increased by digitonin in a dose-dependent
manner (Figure 4A, B). Addition of 40 mg/ml or 50 mg/ml
digitonin resulted in similar concentration curves as application of
EGCG alone during the first 10 h. Only after more than 10 h an
effect of these digitonin concentrations was detected. A clear shift
towards an increased toxic effect of EGCG by digitonin
application was only reached by a combination of EGCG with
60 mg/ml or 70 mg/ml digitonin. Already after 4 h the percentage
of living parasites rapidly decreased at a fixed EGCG concentra-
tion of 50 mg/ml (Figure 4A). At a higher EGCG concentration
(200 mg/ml) the additional effect of digitonin was more pro-
nounced and detected already after less than 2 h. The dose-
response curves showed a clear time-dependent decrease of living
parasites of the combination treatment after 6 h and 12 h
(Figure 5). The IC50 value could be decreased by 96% from
50262 mg/ml (109563 mM) for EGCG alone to 2061 mg/ml
(4462 mM) in the presence of 60 mg/ml digitonin 6 h after
application. The IC50 value after 12 h was also decreased by 70%
from 5462 mg/ml (11864 mM) in the absence of digitonin to
1660.84 mg/ml (3562 mM) in the presence of 60 mg/ml digito-
nin. The calculated fractional inhibitory concentration gFIC of
0.25 demonstrated a toxic synergism between both drugs (for
calculation see material and methods).
No Synergistic Effects between EGCG and Digitonin on
Sporozoite Motility
We next tested for a possible synergistic effect of EGCG
together with digitonin on the inhibition of sporozoite motility
after 40 minutes. EGCG was applied over the entire concentration
range together with 50, 60 and 70 mg/ml digitonin (Figure 6). The
Figure 2. Inhibition of gliding motility by EGCG. The percentage
of gliding parasites after treatment with EGCG in a range from
3.125 mg/ml to 500 mg/ml (6.75 mM to 1090 mM) was determined. A)
Inverted maximum projections of time-lapse movies from untreated
sporozoites and sporozoites treated with 100 mg/ml or 500 mg/ml. As
sporozoites glide in circles, maximum projections of motile parasites
show up as circles. At 100 mg/ml more than 50% of gliding was
inhibited; at 500 mg/ml no motility was detected. Scale bar: 25 mm. B)
Concentration dependent inhibition of parasite gliding motility after
40 min of incubation with EGCG. Weighted averages of triplicates (each
usually contained between 200 and 300 sporozoites) and standard
errors of the mean of the percentage of motile parasites were
calculated for each concentration point, normalised to the control
(set to 100%) and plotted over the applied EGCG concentrations. IC50
value: 6361 mg/ml (13761 mM). C) Inhibition of hepatocyte infection of
sporozoites in the presence of various concentrations of EGCG.
Sporozoites were either pre-incubated for 40 minutes in EGCG
containing medium before addition to hepatocytes (light grey) or not
pre-incubated (dark grey). The dashed black lines mark the IC50 which
is aorund 130 mg/ml after pre-incubation.
doi:10.1371/journal.pone.0008682.g002
Figure 3. Permeabilisation efficiency of digitonin. A) Snap shots
of non-treated sporozoites and sporozoites treated with 250 and
500 mg/ml digitonin after 40 min of incubation. The upper panels show
the green, the lower panels the red fluorescent signal. Scale bar: 25 mm.
B) The percentage of living parasites (normalised to the control set to
100%) plotted over the concentrations of digitonin at the beginning of
the experiment (filled squares), after 6 h (open circles) and 12 h
(crosses). Weighted averages of triplicates (each usually contained
between 200 and 300 sporozoites) and standard errors of the mean are
shown.
doi:10.1371/journal.pone.0008682.g003
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effect of EGCG compared to the administration of EGCG alone.
A significant shift of the EGCG curve was shown for EGCG in
combination with 60 mg/ml digitonin. This parallel shift towards
the curve of non-permeabilised parasites is typical for a synergistic
effect of the adjuvant with the drug. The IC50 40 minutes after the
application of the combination treatment was reduced by 20% to
5261 mg/ml (11362 mM) for the inhibition of gliding motility for
a combination treatment with 60 mg/ml digitonin (IC50 for
EGCG alone 6361 mg/ml (13761 mM)). The application of
70 mg/ml digitonin also caused a shift of the curve. However, the
measurements revealed not only a motility inhibiting but also a
lethal effect of 70 mg/ml digitonin in combination with EGCG
doses over 100 mg/ml (Figure 6) (data not shown).
Since a shift of the EGCG curve was only achieved with a
digitonin concentration between 60–70 mg/ml, an intermediate
concentration of 65 mg/ml digitonin was applied together with
EGCG (Figure 6). No parallel shift of the EGCG curve for 65 mg/
ml digitonin compared to EGCG together with 60 mg/ml
digitonin was detected. The percentage of gliding parasites was
also similar for the 60 mg/ml and the 65 mg/ml dose of the
adjuvant. Treatment with 65 mg/ml digitonin revealed a sharper
decline of the regression concerning the EGCG range from 50–
100 mg/ml suggesting an additive effect of digitonin. The
calculated fractional inhibitory concentration gFIC of 0.82
demonstrated that there is no synergism between EGCG and
digitonin concerning inhibition of gliding motility (for calculation
see material and methods).
Discussion
Here we tested (i) a recently developed assay for its utility in
screening for inhibitors of Plasmodium sporozoite motility and (ii)
Figure 4. Cytotoxicity of EGCG combined with digitonin. The percentage of living parasites (normalised to the control set to 100%) after
exposure to a low A) or high B) concentration of EGCG, combined with digitonin in a range from 40 to 70 mg/ml (40=grey line with filled circle;
50=grey line with cross; 60=light grey line with filled rhombi; 70=light grey line with open triangle) decreases with time. The values were averaged
over triplicates (each containing 200 to 300 parasites) and normalised to the cytotoxicty assay of 40 mg/ml to 70 mg/ml digitonin without EGCG
application measured over 18 h since digitonin alone showed a lethal effect (not shown, but partially included in Figure 3).
doi:10.1371/journal.pone.0008682.g004
Figure 5. Synergistic cytotoxicity of EGCG and digitonin. The
percentage of living parasites over (normalised to the control set to
100%) the concentrations of EGCG (dashed grey lines, already shown in
Figure 1) and EGCG with 60 mg/ml (115 mM) digitonin was plotted at
the beginning of the experiment (straight line on top), after 6 h
(without digitonin=dashed black line with filled squares; with
digitonin=black line with filled squares) and 12 h (without digito-
nin=dashed grey line with open circles; with digitonin=grey line with
open circles). Weighted averages of triplicates (each usually contained
between 200 and 300 sporozoites) and standard errors of the mean are
shown normalised to the death curves of digitonin alone. The dashed
black lines mark the IC50 values. The IC50 values of the cytotoxic effect
of EGCG are reduced from 50262 mg/ml (109563 mM) to 2061 mg/ml
(4462 mM) after 6 h and from 5462 mg/ml (11864 mM) to 1661 mg/ml
(3562 mM) after 12 h by 60 mg/ml digitonin application.
doi:10.1371/journal.pone.0008682.g005
Figure 6. Inhibition of gliding motility by EGCG and digitonin.
Concentration dependent inhibition of gliding sporozoites (normalised
to the control set to 100%) treated with different EGCG concentrations
and permeabilised with 50 (open circles), 60 (filled squares), 65 (crosses)
and 70 (filled rhombi) mg/ml digitonin. IC50 value of EGCG and 60 mg/
ml digitonin for inhibition of gliding motility: 5261 mg/ml (11362 mM).
The EGCG curves based on 60 mg/ml and 65 mg/ml are similar, except of
a sharper decline of the EGCG curve with 65 mg/ml digitonin.
doi:10.1371/journal.pone.0008682.g006
Effects of EGCG on Malaria
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together with the saponin digitonin on cytotoxicity and inhibition
of motility. This revealed that such a combination of natural
compounds results in a more efficient effect on a target cell than
application of a single drug as monotherapy. While digitonin
showed an additive effect to EGCG on inhibiting motility, it
showed a synergistic effect on inhibiting sporozoite survival.
However, EGCG inhibited the motility rapidly after 40 minutes,
while causing sporozoite death only after several hours.
Most studies on the identification of potential drugs targeting
malaria parasites are aimed at the blood stages of the parasites. So
far, three studies demonstrated an antimalarial potential of EGCG
on blood stages of Plasmodium falciparum [10,20,21]. To test the
influence of EGCG on sporozoites, we performed cytotoxicity and
motility assays. This revealed that EGCG inhibited the gliding
motility of sporozoites in a time-dependent manner at concentra-
tions where no toxic effect was detectable. Indeed, eight fold
higher concentrations of EGCG were necessary to induce lethal
effects on sporozoites than for inhibiting the motility (Figure 1 and
2). An EGCG concentration of 63 mg/ml caused a 50% inhibition
of motility after 40 min (Figure 2). However, the same concen-
tration of EGCG caused a 50% cytotoxic effect only after about
12 h (Figure 1). In the context of a natural infection, inhibition of
sporozoite gliding in the skin or on the liver endothelium would be
enough to stop the parasite from infecting the liver and thus
interrupting its life cycle. Intriguingly, we found that a higher
concentration of EGCG is needed to reduce liver cell infections to
the same level as needed to reduce the number of motile
sporozoites (Figure 2C). This suggests that EGCG has no
detrimental effect on hepatocytes and indicates that gliding
motility does not strictly correlate with successful infection.
Indeed, it is well known that sporozoites migrate through a
number of cells before finally invading a hepatocyte for
differentiation into merozoites [27]. Thus efficient gliding might
be more relevant for migration in tissue or through cells than for
invasion.
But how does EGCG inhibit motility and cause cytotoxicity?
EGCG is a polyphenol, which can form several hydrogen and
ionic bonds with proteins, thus modulating their 3D structure
[1,2]. At physiological pH, the eight phenolic hydroxyl groups of
EGCG are partly dissociated. In our assay, we hypothesise that
EGCG binds to adhesion molecules on the parasite surface, e.g.
TRAP or CSP that are important for motility and thus impair
gliding [28,29]. The non-covalent bonds could lead to an
inactivation of the surface proteins and the parasites could thus
be rendered immotile. Such unspecific effects are suggested by the
high IC50 value (mM range instead of nM range for specific
interactions). However, some authors suggested direct functional
inhibitory interactions of EGCG even at similarly high concen-
tration (200 mM) [12,20]. Alternatively, EGCG could also interact
with other proteins in the medium, for example BSA, which is
needed for efficient gliding motility. If EGCG would bind to BSA
and in addition on the sporozoite, a quenching effect of BSA could
explain the observed high concentration of EGCG needed for
inhibition of motility. However, the data in Figure S1 show that
decreasing the BSA concentrations from 1% to 0.25% does not
change the effect of EGCG significantly. Only at higher
concentrations of BSA quenching was observed (Figure S1).
Clearly, even higher EGCG concentrations may be necessary to
achieve a sporozoite effect in vivo. Extrapolating from the in vitro
assay, EGCG might in vivo not only bind to sporozoite adhesion
proteins on the surface of the parasites but also to receptors on the
host cell or proteins within the tissue. Many side effects could
further follow the application of EGCG since the polyphenol
inhibits different proteins non-selectively. We therefore reasoned
that the application of an adjuvant could increase the effect of
EGCG on target cells, decrease the necessary efficient dosage of
EGCG and thus reduce adverse reactions. This could be achieved
in different ways causing either a simple additive or a synergistic
effect. Using the membrane permeabilising saponin digitonin, we
measured digitonin applications of different concentrations in
cytotoxicity assays over 18 h alone to normalise the data of the
combination treatment of EGCG and digitonin against the toxic
effect the adjuvant already determines alone. After normalisation,
we observed an additional effect on inhibition of gliding motility
and, importantly, a synergistic effect on parasite killing. Amphi-
philic saponins have detergent properties that can disrupt
membrane fluidity, inhibit the function of membrane proteins
such as ion channels and disrupt the membrane [1,2]. Therefore,
saponins can exert either an additive or synergistic effect by
disturbing the cell membrane or promoting the transport of
EGCG.
Consequently, digitonin could also enhance in both possible
ways the effect of EGCG on gliding motility. For example, a
membrane disrupting effect could potentially lead to an additional
effect of EGCG on the parasite motor machinery, which is
localised underneath the plasma membrane. Intracellular proteins
involved in motility could also be targeted by EGCG [30]. The
mode of action is non-synergistically since our data leads to a
calculated gFIC of 0.82. Based on the guideline paper for the FIC
index by Hall et al. we suggest that digitonin enhances the action
of EGCG on gliding motility rather by a dominant additive effect
[31].
However, a clear synergistic effect (gFIC=0.25) of EGCG with
digitonin on the inhibition of sporozoite survival was shown. It is
likely that besides causing membrane disruption digitonin
promotes the transport of EGCG inside the parasite. Due to the
later effect of EGCG, the polyphenol might enter over time he
parasite to exert the toxic effect. EGCG might also induce
signalling pathways from the cell surface that lead to cell death.
The high concentration necessary to inhibit motility and the late
action on sporozoite survival along with the low bioavailability
[32] (several tens of litres of green tea would have to be consumed
to reach inhibitory concentrations in the blood) show that EGCG
itself can not be developed into an anti-malarial drug. However,
both compounds can be considered as lead structures for drugs
against other ailments.
Importantly, we could demonstrate that the motility apparatus
of sporozoites can be in general targeted by drugs. Although our
tested combination will not be useful for fighting malaria, our
results validate a recently developed visual screening method for
drug discovery based on automated analysis of sporozoite motility
[26]. This assay could thus lead to the discovery of compounds
that inhibit or kill the malaria parasite before it even enters the first
host cell for replication.
In conclusion, by using a new visual screening approach we
could show the advantage of plant metabolites mixtures resulting
in a cytotoxic synergistic effect on a pathogen. The fact that such
synergism was found suggests new avenues in screening for
inhibitory molecules and the development of multitarget drug
cocktails.
Materials and Methods
Preparation of Plasmodium Sporozoites
Plasmodium berghei (strain NK65) sporozoites constitutively
expressing cytoplasmic green fluorescent protein (GFP) under
the control of the stage specific circumsporozoite (CS) promoter
Effects of EGCG on Malaria
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Anopheles stephensi mosquitoes (Sda500 strain) were raised at 28uC,
75% humidity, under a 13/11 h light/dark cycle and maintained
on 10% sucrose solution and 10 mg para-aminobenzoic acid in a
standard insectary. NMRI mice (Charles River) were infected by
intraperitoneal injection of 200 ml frozen parasite stock. All animal
experiments were performed concerning FELASA category B and
GV-SOLAS standard guidelines. Animal experiments were
approved by the German authorities (Regierungspra ¨sidium
Karlsruhe, Germany), 1 8 Abs. 1 Tierschutzgesetz (TierSchG).
The next 3–4 days Giemsa-stained (1:10 solution, BDH) blood
smears of the infected mice were analysed and the parasitaemia
was determined. At a sufficient parasitaemia the blood was gained
by heart puncture and about 20 million parasites were transferred
into a naı ¨ve mouse. Exflagellation of male gametocytes was
checked three to four days later. If exflagellation occurred between
10–14 min with at least two events per field of view, the mouse
was anaesthetized with 100–150 ml 10% ketamin/2% xylazin in
PBS and fed to Anopheles stephensi mosquitoes (3–5 d after
emergence). After infection the mosquitoes were maintained at
20uC and 80% humidity in standard incubators. 17–23 d after
infection of the mosquitoes, the fluorescent sporozoites were
isolated from infected salivary glands, and suspended in cold
RPMI-1640 (PAA) supplemented with 1% bovine serum albumin
(BSA, Roth).
Comparison of the gliding capacity of P. berghei sporozoites in
medium containing various concentrations of BSA showed that
sporozoites moved as robustly in medium containing 1% BSA
than in medium containing 3% BSA. However, at 0.5% and
0.25% BSA the number of motile sporozoites dropped drastically
(Figure S1A). We therefore performed all experiment in the
presence of 1% BSA. Indeed no difference of the effect of EGCG
on sporozoite motility was found between media containing 1%,
0.5% and 0.25% BSA (Figure S1B). But the reliability of
movement decreased with decreasing BSA concentrations as
evidenced by the increased standard deviation (Figure S1B).
Cytotoxicity and Motility Assays
A stock solution of 4 mg/ml (8726 mM) EGCG was prepared in
RPMI and diluted to EGCG concentrations ranging from
12.5 mg/ml to 2000 mg/ml (27 mM to 4400 mM) to measure dose
response curves. Further a stock solution of 2 mg/ml (1627 mM)
digitonin was prepared in RPMI and diluted to concentrations
ranging from 10 mg/ml to 1000 mg/ml (8 mM to 813 mM).
In every experiment 8–10 different conditions were measured
for both, the cytotoxicity or motility assay. For both assays 23 mlo f
the medium containing isolated sporozoites were placed in one
well of a 384 well plate (with optical glass bottom), which was then
centrifuged at 375 g for 5 min to sediment the parasites.
Following, 25 ml of EGCG (Sigma) or digitonin (Sigma) were
mixed with 2 ml SYTOX-Orange (100 mM stock, Invitrogen) and
added to the parasite solution. SYTOX-Orange binds to the DNA
of permeabilised parasites and is therefore used as a marker to
generate death curves in the cytotoxicity assay (life-dead assay).
Microscopy and Image Analysis
For cytoxicity assays the total number of living (green
fluorescence) and dead (red fluorescence, SYTOX-Orange)
parasites present in each field of view was counted over 18 h
with images of both channels taken every 10 min. For motility
assays sporozoites were incubated for 40 min with the different
drug concentrations at room temperature. Following, images were
collected with a time lapse of 0.5 Hz for 100 frames in the green
channel. To analyse whether all parasites were still alive in the
motility assays a short time lapse of the SYTOX-Orange signal
(red channel) and the GFP signal was taken before and after 100
frames. Imaging was performed at room temperature (24uC) in an
air-conditioned imaging suite with an inverted Axiovert 200M
Zeiss microscope using a GFP filterset to detect green fluorescence
(450 nm/510 nm) [26]. The red fluorescent SYTOX-Orange
signal was detected with a RFP filter set (546 nm/575–640 nm).
Images were collected with a Zeiss Axiocam HRM using the
Axiovision 4.6 software and a 10x Apoplan objective (NA=0.25).
For each well three different regions of interest (ROI) were
recorded to yield triplicates. Each ROI usually contained between
200 and 300 sporozoites. Thus, approximately 700 sporozoites
were imaged for every concentration in one experiment. Every
experiment was repeated at least three times. All image series were
imported to ImageJ for analysis. For life dead assays the total
number of green fluorescent, living parasites was automatically
counted applying a custom-made ImageJ plugin (Hegge et al., in
preparation). For motility assays the movies were analysed with
regard to the speed (mm/s) of gliding parasites by applying the
ImageJ plugin ToAST [26]. In brief, after background subtraction
and application of an automatic threshold, the plugin automat-
ically processes the data, detects the different motility patterns and
calculates the gliding speed. Weighted averages and weighted
standard errors of the mean (SEMs) were calculated in percent and
normalised to the control set to 100%.
Infection Assay
To test the effect of inhibiting sporozoite motility on hepatocyte
infection we cultivated Huh7 cells in Dulbecco’s modified Eagle’s
medium supplemented with 10% fetal calf serum and antibiotics.
Sporozoites dissected in RPMI with 1% BSA and treated with
various concentrations of EGCG were added to the cells in two
different ways. Sporozoites were either directly added to the cells
or pre-incubated for 40 minutes at room temperature before being
added to the hepatocytes. Liver cell infection was performed in a
similar way as described in Silvie et al [33]. Cultivated in 8-
chamber plastic Lab-Tek (Thermo Fisher Scientific, nunc) slides
the Huh7 cells were incubated with the sporozoites (10.000 for
each condition) treated with 0, 65, 130, 200 or 500 mg/ml EGCG
for one hour at room temperature and two hours at 37uC. Assays
were performed in duplicates (without pre-incubation) and in
triplicates (with pre-incubation). After 48 h, exoerythrocytic forms
were revealed using primary antibodies against Plasmodium heat
shock protein 70, followed by the anti-mouse Alexa Fluor 488
secondary antibody. DAPI (Sigma) was used to stain nuclei.
Images were acquired with the same microscopic setup as
described earlier. Infected hepatocytes were manually counted
and noted as percentage of the total hepatocytes after 48 h of
incubation. The percentage values were then normalised to the
control wells of liver cells infected with non-treated sporozoites.
Calculation of IC50 and gFIC
The graphs, logarithmic regression and IC50 values were
generated and calculated using GraphPrism3 (GraphPad Soft-
ware). Synergism of drug and adjuvant was evaluated by
calculating the fractional inhibitory concentration index (gFIC)
as follows: gFIC=(minimal inhibitor concentration (MIC) of
combination A + B)/(MIC of drug A alone) + (MIC of combination
A + B)/(MIC of drug B alone) [34]. The unit of the MIC values is
mg/l. A synergistic effect is indicated if the FIC index is smaller
than 0.5 (significance level). The MIC values were defined as the
concentrations when 10% of the parasites were dead or when 10%
of the gliding motility was inhibited.
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The cytotoxic synergism between EGCG and digitonin was
evaluated by calculating the fractional inhibitory concentration
index (gFIC). For EGCG (=A) a MIC value of 36 mg/ml
(79 mM), for digitonin (=B) a MIC value of 22 mg/ml (18 mM)
and for the combination of the whole EGCG concentration range
with 60 mg/ml digitonin (A+B) a MIC value of 3 mg/ml (6.5 mM)
was determined from the death curves after 6 h (Figure 1B, 3B).
Calculation of gFIC for Inhibition of Motility
The gFIC was calculated for the inhibition of motility by
EGCG combined with digitonin. For EGCG (=A) a MIC value of
15 mg/ml (33 mM), for Digitonin (=B) a MIC value of 60 mg/ml
(49 mM) and for the combination of the whole EGCG concentra-
tion range with 60 mg/ml Digitonin (A+B) a MIC value of 9 mg/
ml (20 mM) was determined from the inhibition curves after 40
minutes (Figure 2B, 3B).
Supporting Information
Figure S1 Gliding motility of sporozoites and bovine serum
albumine. A) The percentage of gliding parasites depends on the
concentration of bovine serum albumine (BSA) concentration.
Normally gliding studies are performed with 3% BSA. We reduced
it to 1% since the percentage of sporozoite gliding is still similar.
However, decreasing the BSA concentration further resulted in a
drastic reduction of gliding parasites. In addition, the standard
deviation increases with decreasing BSA concentrations. B)
Epigallocatechin gallate (EGCG) inhibits gliding of sporozoites.
No change in the efficiency of EGCG inhibition was found for
sporozoites gliding in the presence of 0.25%, 0.5%, or 1% of
BSA. However, in the presence of 3% BSA, the efficiency of
inhibition was decreased as markedly more parasites were gliding.
(*: p,0.05; n.s.=not significant)
Found at: doi:10.1371/journal.pone.0008682.s001 (0.13 MB TIF)
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